Rivaroxaban increased the risk of major bleeding and intracranial hemorrhage but not the risk of fatal bleeding.
利伐沙班增加了严重出血和颅内出血的危险，但不增加致死性出血的危险。
2
Conclusion: there is a good effect of the Rivaroxaban to take precautions against formation of the Phlebothrombosis.
结论：利伐沙班对预防下肢深静脉血栓形成可获得良好的效果。
3
CONCLUSIONS in patients with a recent acute coronary syndrome, rivaroxaban reduced the risk of the composite end point of death from cardiovascular causes, myocardial infarction, or stroke.